Biologische Hochschulschriften (Goethe-Universität)
Refine
Year of publication
Document Type
- Doctoral Thesis (854)
- Article (12)
- Part of Periodical (2)
- Bachelor Thesis (1)
- Diploma Thesis (1)
Has Fulltext
- yes (870)
Is part of the Bibliography
- no (870)
Keywords
- Gentherapie (7)
- NMR-Spektroskopie (6)
- gene therapy (6)
- Elektrophysiologie (5)
- Molekularbiologie (5)
- RNA (5)
- Schmerz (5)
- Apoptosis (4)
- Arzneimitteldesign (4)
- Carotinoide (4)
Institute
- Biowissenschaften (552)
- Biochemie und Chemie (169)
- Biochemie, Chemie und Pharmazie (79)
- Pharmazie (32)
- Institut für Ökologie, Evolution und Diversität (21)
- Georg-Speyer-Haus (6)
- Medizin (5)
- Geowissenschaften (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
Ischemic injuries of the cardiovascular system are still the leading cause of death worldwide. They are often accompanied by loss of cardiomyocytes (CM) and their replacement by non-functional heart tissue. Cardiac fibroblasts (CF) play a major role in the recovery after ischemic injury and in the scar formation. In the last few years researchers were able to reprogram fibroblasts into CM in vitro and in murine models of myocardial infarction using various protocols including a cocktail of microRNAs (miRs). These miRs can target hundreds of messenger RNAs and inhibit their translation into proteins, potentially regulating multiple cellular signaling pathways. Because of this, there has been a rising interest in the use of miRs for therapeutic purposes. However, as different miRs have different effects in different cells, there is the danger of causing serious side effects. These could be alleviated by enacting a cell-specific transport of miRs, for example by using aptamers. Aptamers are usually short strands of DNA or RNA, which can fold into a specific three-dimensional confirmation which allows them to bind specifically to target molecules. Aptamers are commonly selected from a large library for their ability to bind to target molecules using a procedure called SELEX. Aptamers have already been used to transport miRs into cancer cells.
In this thesis, we first established the transport of miRs into cells of the cardiovascular system using aptamers. MiR-126 is an important part of the signaling in endothelial cells (EC), protects from atherosclerosis and supports angiogenesis, which is why we chose it as a candidate to transport into the vasculature. We first tested two aptamers for their ability to internalize into EC and fibroblasts. Both the aptamer for the ubiquitously expressed transferrin receptor (TRA) and a general internalizing RNA motif, but not a control construct, could internalize efficiently into all cell types tested. We then designed three chimeras (Ch) using different strategies to connect TRA to miR-126. While all chimeras could internalize efficiently, only Ch3, which connects TRA to Pre-miR-126 using a sticky bridge structure, had functional effects in EC. Ch3 reduced the protein expression of VCAM-1 in EC and increased the VEGF induced sprouting of EC in a spheroid-sprouting assay. Treatment of breast cancer cells with Ch3 emulated the effects of treatment with classical miR-126-3p and miR-126-5p mimics. In the SK-BR3 cell line Ch3 and miR-126-3p reduce the viability of the cells while they reduce recruitment of EC by the MCF7 cell line. miR-126-5p had no apparent effect in the SK-BR3 line, but increased viability of MCF7 cells, as did Ch3. This implies that Ch3 can be processed to both functional miR-126-3p and miR-126-5p in treated cells.
We were unable to achieve a reprogramming of adult murine cardiac fibroblasts into cells resembling CM using the cocktail of 4 miRs. This indicates that the miR-mediated transdifferentiation is only possible in neonatal fibroblasts. The effects in mice after an AMI might possibly be caused by an enhanced plasticity of fibroblasts in and close to the infarcted area.
We also screened to find aptamers specifically binding to cells of the cardiovascular system. We used two oligonucleotide libraries in a cell-SELEX to select candidates which bind to CF, but not EC. We observed that only the library which contains two randomized regions of 26 bases showed an enrichment of species binding to fibroblasts. We then sequenced rounds 5-7 of the SELEX and analyzed the data bioinfomatically to select 10 candidate aptamers. All candidates showed a strong binding not only to CF, but also EC. This indicates that the selection pressure against species binding to EC was not high enough and would have to be increased to find true CF-aptamers. Four promising candidates were also analyzed for their potential to be internalized and we surprisingly found that all of them were internalized by EC and CF more efficiently than TRA. The similar behavior of the candidates implies that they possibly share a ligand, which is expressed both by EC and CF, but more prominently by the latter.
This work demonstrates the possibility of using aptamers to transport miRs into cells of the cardiovascular system. It also shows that it is possible to select aptamers for non-cancerous mammalian cells, which has not been done before. It is reasonable to assume that a refinement of the cell-SELEX will allow selection of cell-specific aptamers. Due to the failure of reprogramming of adult fibroblasts into induced cardiomyocytes we were unable to test whether a miR-mediated reprogramming might be inducible using aptamer transported-miRs. Ultimately, aptamer mediated transport of miRs is a feasible and promising therapeutic option for the treatment of cardiovascular diseases and other disorders like cancer.
The development of the atrioventricular (AV) canal and the cardiac valves is tightly linked and a critically regulated process. Anomalies in components of the involved pathways can lead to congenital valve malformations, a leading cause of morbidity and mortality in neonates. Myocardial Bmp as well as endocardial Notch and Wnt signaling have been identified as critical factors for the induction of EMT during the formation of the endocardial cushions and cardiac valves. Of these, canonical Wnt signaling positively regulates endocardial proliferation and EMT but negatively regulates endocardial differentiation. Further, elevated Wnt signaling leads to the ectopic expression of myocardial Bmp ligands suggesting a high level of integration of the involved pathways and crosstalk amongst the different cardiac tissues.
Here we have identified a novel role for Id4 as a mediator between Bmp and Wnt signaling. Id4 belongs to the Id family of proteins and is known to be involved in bone and nervous system development. We found that in zebrafish, id4 is expressed in the endocardium of the AV canal at embryonic stages and throughout the atrial chamber in addition to AV canal, in adults. Using transcription activator-like effector nucleases (TALENs) we established an id4 mutant allele. Our analysis shows that id4 mutant larvae are susceptible to retrograde blood flow, and show aberrant expression of developmental valvular markers. These include expanded expression domains of markers like bmp4, cspg2a and Alcam. In contrast, valve maturation as assessed by the expression of spp1 is considerably reduced in id4 mutants. Using conditional transgenic systems, along with elegant in vivo imaging of transgenic reporter lines, we further found that id4 is a transcriptional target of Bmp signaling, and it is capable of dose dependently restricting Wnt signaling in the endocardium of the Atrioventricular Canal.
Taken together, our data identifies Id4 as a novel player in Atrioventricular Canal and valve development. We show that Id4 function is important in valve development acting downstream of Bmp signaling by restricting endocardial Wnt to allow valve maturation
Die vorliegende Studie vermittelt einen epidemiologischen Überblick über das mit Haut- und Nagelläsionen assoziierte Pilzspektrum im Westen Panamas. Hierzu wurden Proben von vermutlich durch Pilzinfektionen verursachten Haut- sowie Nagelläsionen gesammelt und zum Anlegen von Kulturen verwendet. Die isolierten Pilze wurden basierend auf dem D-H-S System (Rieth), anhand morphologischer Merkmale, rDNA Sequenzdaten sowie phylogenetischen Analysen klassifiziert und mit Hilfe von Literaturdaten sowie physiologischen Eigenschaften als saprotrophe, opportunistische oder pathogene Organismen beurteilt. In Panama wurden 52 Proben von 51 Personen gesammelt, wobei das Material von 42 Haut- und Nagelläsionen der Füße, vier Läsionen der Fingernägel, zwei Chromomykosen, einer Tinea nigra und drei sonstigen Hautläsionen stammt. Bei 75 Prozent (n = 39) der Proben konnten Pilze kultiviert und insgesamt 201 Pilzstämme isoliert und subkultiviert werden. Hiervon wurden 50 Isolate (24,9 %) als Dermatophyten, 24 Stämme (11,9 %) als Hefen und 127 Isolate (63,2 %) als Schimmelpilze klassifiziert. Bei 19 Probanden (48,7 %) konnten Dermatophyten isoliert werden, wobei aus dem Probenmaterial von 12 Personen (63,2 %) ebenfalls andere Pilzarten nachgewiesen wurden. Von zwei Läsionen (5,1 %) wurden nur Hefen isoliert, wobei einmal eine Schwarze Hefe kultiviert wurde. In dem Material acht weiterer Proben (20,5 %) wurden Schimmelpilze und Hefestämme nachgewiesen und bei zehn Probanden (25,6 %) konnten aus dem Probenmaterial nur Schimmelpilze kultiviert werden. 172 Isolate wurden taxonomisch klassifiziert und 44 Arten aus 25 Gattungen, 17 Familien, 15 Ordnungen, sechs Klassen sowie den Abteilungen Ascomycota oder Basidiomycota zugeordnet. Die Ascomyceten stellen mit 164 Stämmen 40 verschiedener Arten aus 23 Gattungen, 15 Familien, 11 Ordnungen und vier Klassen die am häufigsten isolierte und vielfältigste Gruppe dar, während die Basidiomycota nur mit acht Isolaten vier verschiedener Arten zwei unterschiedlicher Gattungen, Familien, Ordnungen und Klassen nachgewiesen wurden. Im Rahmen dieser Arbeit wurden in Panama die anthropophilen Dermatophyten Trichophyton rubrum und T. interdigitale dokumentiert, wobei T. rubrum die am häufigsten isolierte Art darstellt. Kultivierte Hefen waren Candida albicans, C. duobushaemulonii, C. tropicalis, Hortaea werneckii, Sporobolomyces sp., Trichosporon asahii, T. japonicum und T. montevideense. Die Schimmelpilze stellen die größte und ökologisch diverseste Organismengruppe der kultivierten Pilze dar. So wurden von den untersuchten Läsionen sowohl humanpathogene Erreger, als auch opportunistische Arten und rein saprotrophe Pilze sowie mehrere Vertreter wahrscheinlich bisher nicht wissenschaftlich beschriebener Arten bzw. Gattungen nachgewiesen. Aus dem Probenmaterial wurden die Pilze Acremonium collariferum, Aspergillus awamori, A. clavatus, A. flavus, A. giganteus, A. heteromorphus, A. niger, A. ochraceus, A. sclerotiorum, A. versicolor, Chaetomium globosum, Chrysosporium tuberculatum, Cladosporium sphaerospermum, C. tenuissimum, Curvularia geniculata, C. lunata, Fonsecaea pedrosoi, Fusarium oxysporum, F. solani, Lophotrichus bartlettii, Microascus cinereus, Neoscytalidium dimidiatum, Penicillium commune, Scolecobasidium sp., Scopulariopsis carbonaria, S. croci, Verticillium cf. epiphytum und Wardomycopsis litoralis isoliert. Zudem wurden vier Isolate von zwei vermutlich neuen Arten der Gattung Acremonium (Bionectriaceae, Hypocreales), zwei Stämme mit einer genetischen Affinität zu der Gattung Cryptendoxyla (Cephalothecaceae, Sordariales) und jeweils ein mit den Gattungen Fusicladium (Venturiaceae, Venturiales), Knufia (Trichomeriaceae, Chaetothyriales) bzw. Rhexothecium (Eremomycetaceae, Dothideomycetidae) assoziierter Stamm kultiviert. Im Rahmen dieser Studie wurden A. giganteus, C. tenuissimum, L. bartlettii, S. carbonaria, S. croci, V. epiphytum und W. litoralis erstmalig von Mykosen des Menschen dokumentiert und die in der Literatur als Verursacher sowie Besiedler von Haut- und Nagelläsionen beschriebenen Organismen A. clavatus, A. flavus, A. niger, A. ochraceus, C. tropicalis, C. globosum, C. sphaerospermum, C. lunata, F. oxysporum, M. cinereus, P. commune, T. asahii, T. japonicum und T. montevideense wurden das erste Mal in klinischem Probenmaterial aus Panama nachgewiesen. Die Arten A. awamori, A. heteromorphus, C. globosum, C. tenuissimum, L. bartlettii, M. cinereus, P. commune, S. croci, T. asahii, T. japonicum, T. montevideense, V. epiphytum, W. litoralis und die Gattung Scolecobasidium wurden zudem erstmalig für Panama dokumentiert. Die Isolation von W. litoralis ist ebenfalls der erste Nachweis dieses Pilzes außerhalb von Spanien und auf dem amerikanischen Kontinent. Die große Anzahl im Rahmen dieser Arbeit beschriebener, bisher für die Wissenschaft unbekannter bzw. nicht in Panama dokumentierter Pilzarten lässt auf eine große mykologische Biodiversität in Panama schließen und zeigt den Bedarf weiterer Forschung.
Panama, a small country between the major continents of North and South America, is one of the lesser studied regions in Central America, but is recognized for its mega-biodiversity. This is particularly true for Eastern Panama, which I am considering as the easternmost portion of the country, covering the area from the Chepo, which is also the beginning of the San Blas mountain range, towards east, up to the Darien Mountain range on the border with its neighboring country Colombia. In the lowland region I visited two physiographic areas: the Isthmian-Atlantic Moist Forests (IAMF) and the Chocó-Darién Moist Forests (CDMF). In the IAMF I worked at the localities of Río Mono, Wacuco, La Moneda, Arretí, Metetí, Filo del Tallo, and Laguna de Matusagaratí. In the CDMF I visited the localities of Cruce de Mono, Cana, Garachiné, Sambú, and Pavarandó. And I have worked in the highlands of Darién (DM), Majé (MM), Jingurudó-Sapo (JSM), Pirre (PM) and San Blas (SSM) in the highlands.
Before my research, 138 reptile and 104 amphibian species had been reported for EP. From 2008 to 2013, I collected specimens to evaluate the diversity of amphibians and reptiles for this region. I applied an integrative approach to evaluate the taxonomy, diversity, biogeography, and conservation of the herpetofauna of EP. I included analyses of morphometrics, molecular genetics (e.g. barcoding), biogeography, bioacoustics (in anurans), hemipenial morphology (in squamates), and ecology. This is the first regional evaluation of the biodiversity in EP applying integrative taxonomy. Aside from morphological and bioacoustic data, my work is based on the barcoding of 608 specimens, from which I obtained 16S mtDNA for 486 specimens and COI mtDNA for 455. In total I have got sequences for 69.2 %of the amphibian and 48.6 % of the reptile species present in EP. For the morphological analyses, I compared 1597 specimens, including my samples complemented by specimens obtained from various museums. The bioacoustic data were obtained from the analysis of 1504 calls of 27 species of frogs. Based on specimens collected in EP and according to external morphology, I could identify 65 species of amphibians and 72 reptiles, but after applying an integrative approach these numbers increased to 79 amphibians and 88 reptiles described species within my collected specimens. Additionally, I uncovered 33 taxonomic units that could not be assigned to any described species until now, 22 of them represent confirmed candidate species (CCS), and 11 were classified as Unconfirmed candidate species (UCS). Thus, increasing the known species of amphibian by 19.4 % and of reptiles by 4.8 %. Currently, there are 145 reptiles and 129 amphibians known to occur in EP. Based on my results, I have initiated several projects to solve taxonomic uncertanties, including the species of the genera Bolitoglossa, Diasporus, Dactyloa, Ecnomiohyla, Lepidoblepharis, and the taxonomic status of the species Pristimantis caryophyllaceus and Norops tropidogaster.
Out of the 22 CCS I found, I described nine species new to science with type locality in EP, six amphibians and four reptiles. Among these is a new species of Bolitoglossa described from Cerro Chucantí, Cordillera de Majé, Provincia de Darién, Panama. Additionally, I include comments on the other species of congeneric salamanders known to occur in the region. Among the tink frogs, only Diasporus quidditus was known to occur in EP. During my field work I collected six additional species of this genus, four of which are new to science, plus two species new for this region.
I also described one new species of Dactyloa (giant anole lizards) related to the former D. chocorum. I synonymized D. chocorum with D. purpurescens, and included information about the other species of the group from EP. The new species of Dactyloa resembles D. ibanezi, D. limon, and D. purpurescens in external morphology but differs from these species in dewlap coloration, dorsal color pattern, morphometrics, and scalation. I discovered one species of the genus Ecnomiohyla, which exhibits significant genetic distances (16S mtDNA gene) and morphological differences to all known Ecnomiohyla species. Along with the description of the new Ecnomiohyla species, I provide detailed comparisons of morphological and molecular characters of almost all members of the genus in Lower Central America, as well as an identification key for the entire genus. Two new species of the genus Lepidoblepharis from EP were described. In the corresponding work, I include an analysis of Lepidoblepharis spp. in the region, including phylogeography and taxonomy. One of the new species, Lepidoblepharis emberawoundule, can be differentiated from most species in the genus by its small size and its low number of lamellae under the fourth toe and finger. The other species described from EP, Lepidoblepharis rufigularis, can be differentiated from all species in the genus by its small size and the reddish throat in males.
Recently, two of the most common types of bone cancers in children and young adults have been proven to exhibit vulnerability to poly(ADP)-ribose polymerase, (PARP) inhibitors (e.g. olaparib, talazoparib). Ewing’s sarcoma (ES) are reported to harbor a fusion gene EWS-FLI1 (85%), inducing tumorigenesis. Additional, as the fusion gene acts as aberrant transcription factor, it similarly induces elevated PARP expression levels sensitizing ES to PARP inhibition. Second, by an exome sequencing approach in a set of primary osteosarcomas (OS) we identified mutation signatures being reminiscent of BRCA deficiency. Therefore, the sensitivity of a panel of OS cell lines to either talazoparib single treatment or in combination with several chemotherapeutic drugs was investigated.
To screen ES tumor cell lines against PARP inhibitors we applied four different PARP inhibitors (talazoparib, olaparib, niraparib and veliparib) that are frequently being used for clinical studies. We combined those PARP inhibitors with a set of chemotherapeutics (temozolomide (TMZ), SN-38, etoposide, ifosfamide, doxorubicin, vincristine and actinomycin D) that are part of the first-line therapy of ES patients. Here, we demonstrate how PARP inhibitors synergize with TMZ or SN-38 to induce apoptosis, whereas the combination of PARP inhibitors with the other drugs are not favorable. By investigation of key checkpoints in the molecular mechanisms of cell death, the pivotal role of the mitochondrial pathway of apoptosis mediating the synergy between olaparib and TMZ was revealed.
Employing talazoparib monotherapy in combination with or without several chemotherapeutic drugs (TMZ, SN-38, cisplatin, doxorubicin, methotrexate and etoposide/carboplatin), the correlation between homologous recombination (HR) repair deficiency (BRCAness) and the response to talazoparib as prototypical PARP inhibitor was validated in different OS cell lines. By calculation of combination indices (CI) and fraction affected (Fa) values, we identified TMZ as the most potent chemotherapeutic drug in combination with talazoparib inducing the mitochondrial apoptotic pathway in OS.
In our studies of two independent tumor entities with contrary genetic background we identified the combination of PARP inhibitor and TMZ as being most effective. Our studies point out that after TMZ induced DNA methylation and concomitant PARP trapping, DNA damage-imposed checkpoint kinase activation consequently induces G2-cell cycle arrest. Subsequent, PARP inhibitor/TMZ causes MCL-1 degradation, followed by activation of BAK and BAX, succeeding in loss of mitochondrial outer membrane potential (LMMP) and activation of downstream effector-caspases in mitochondrial apoptosis. Our findings emphasize the importance of PARP inhibition in order to chemosensitize ES, which express high PARP levels, or OS that bear features of BRCAness.
Xenorhabdus and Photorhabdus bacteria are gaining more and more attention as a subject of research because of their unique yet similar life cycle with nematodes and insects. This work focused on the secondary metabolites that are produced by Xenorhabdus and Photorhabdus. With the help of modern HPLC-MS methodologies and increasingly available bacterial genome sequences, the structures of unknown secondary metabolites could be elucidated and thus their biosynthesis pathways could be proposed, too.
The first paper reported 17 depsipeptides termed xentrivalpeptides produced by the bacterium Xenorhabdus sp. 85816. Xentrivalpeptide A could be isolated from the bacterial culture as the main component. The structure of xentrivalpeptide A was elucidated by NMR and the Marfey´s method. The remaining xentrivalpeptides were exclusively identified by feeding experiments and MS fragmentation patterns.
The second paper described the discovery and isolation of xenoamicin A from Xenorhabdus mauleonii DSM17908. Additionally, other xenoamicin derivatives from Xenorhabdus doucetiae DSM17909 were analyzed by means of feeding experiments and MS fragmentation patterns. The xenoamicin biosynthesis gene cluster was identified in Xenorhabdus doucetiae DSM17909.
The manuscript for publication focused on the biosynthesis of anthraquinones in Photorhabdus luminescens. The Type II polyketide synthase for the biosynthesis of anthraquinone derivatives was discovered in P. luminescens in a previous publication by the Bode group,1 in which a partial reaction mechanism for the biosynthesis has been proposed. The manuscript reported in this thesis however elucidated the biosynthetic mechanisms in a greater detail as compared to the previous publication. Particularly, the biosynthetic mechanism was deciphered through heterologous expression of anthraquinone biosynthesis (ant) genes in E. coli. Additionally, deactivation of the genes antG encoding a putative CoA ligase and antI encoding a putative hydrolase, was performed in P. luminescens. Selected ant genes were over-expressed in E. coli as well as the corresponding proteins purified for in vitro assays. Model compounds were chemically synthesized as possible substrates of AntI and were used for in vitro assays. Here, it was revealed that the CoA ligase AntG played an essential role in the activation of the ACP AntF. Furthermore, a chain shortening mechanism by the hydrolase AntI was identified and was further confirmed by in vitro assays using model compounds. Additionally, this chain shortening mechanism was supported by homology based structural modeling of AntI.
The lung comprises more than 40 different cell types, from epithelial cells to resident mesenchymal cells. These cells arise from the foregut endoderm and differentiate into specialized cell types that form the respiratory and conducting airways, and the trachea. However, the molecular pathways underlying these differentiation processes are poorly understood, and may be relevant to pathological conditions. According to the World Health Organization (WHO), while the respiratory disease rate is increasing, limited treatment and therapies are available. Thus, there is a growing need for new treatment strategies and alternative therapies. Various in vivo and in vitro studies in the model organism mus musculus have already provided valuable information on lung cell lineages and their differentiation and/ or dedifferentiation during development and pathological conditions. However, there remain many questions regarding the key regulators and molecular machinery driving lung cell differentiation and underlying lung progenitor/stem cell biology.
Aiming to develop new animal models for lung diseases, we used a forward genetic careening approach, which provides an unbiased method for identifying genes with important roles in lung cell differentiation, and thus probable contributors to pathological conditions. We conducted an N-ethyl-N-nitrosourea (ENU) mutagenesis screen in mice and used several histological and immunohistochemical approaches to identify and isolate mutants, focusing on mutations associated with cell differentiation rather than those affecting early development and patterning of the respiratory system. Thus, we screened for phenotypes in the respiratory system of pups from the F2 generation at postnatal day 7 and 0 (P7; P0). I specifically screened 114 families. Each F1 male animal is the founder of 5 to 6 F2 female daughters. For each family, at least 4 F2 females per male founder were analyzed. In total, I screened 630 litters at P7 and P0 with 7 pups on average for each litter. As a result of this extensive screening, 11 different phenotypes in 42 different F2s were discovered at primary screen and later just 2 phenotypes recovered in F3 generation of identified carriers. To identify the causative genes for each of these phenotypes, whole exome sequencing will be conducted in the future to identify recurring SNPs; these can subsequently be linked causatively to the resultant phenotype(s) via complementation studies. In turn, these linkages would enable the creation of mutant mice using CRISPR/Cas9 genomic engineering, which would be invaluable to the further study of respiratory development and disease.
Juvenile neuronal ceroid-lipofuscinosis (JNCL) is a rare lysosomal storage disease in children with lethal outcome and no therapy. The origin of JNCL has been traced to autosomal recessive mutations in the CLN3 gene, and ~85% of the JNCL patients harbor a 1.02 kb deletion that removes the exons 7 and 8 and the surrounding intronic DNA (CLN3Δex7/8). So far, structure, function and localization of the CLN3 protein remain elusive. However, there is strong evidence that CLN3 modulates a process or condition that is essential in many cellular pathways. Lipid metabolism and antero-/retrograde transport, two mechanisms CLN3 was previously implicated in, fulfill these requirements. Notably, also a bioactive group of glycosphingolipids referred to as gangliosides is tightly interrelated with these functions. Furthermore, a-series gangliosides have been shown to be involved in the development and sustenance of the brain, where they are essential for neurite outgrowth and cell survival. Defects in ganglioside metabolism were shown to play a crucial role in many lysosomal storage disorders. However, the contribution of gangliosides to NCL pathology is largely unknown.
The present study analyzed central enzymes and metabolites of the a-series ganglioside pathway in a JNCL cell model. The core finding was, thereby, the reduced amount of the neuroprotective ganglioside GM1 in homozygous CbCln3Δex7/8 cells. This was caused by the enhanced action of the GM1-degrading multimeric enzyme complex and in particular, by the upregulation of protein levels and increased enzyme activity of β-galactosidase (Glb1).
Improved binding of Glb1 to substrate-carrying membranes was provided by an increase in LBPA levels. In combination with other smaller alterations in the ganglioside pattern, a shift towards less complex gangliosides became present. The resulting loss of neuroprotection may be the reason for the multifocal pathology in homozygous CbCln3Δex7/8 cells.
The second part of the present study investigated the cellular mechanisms behind the altered ganglioside profile with regard to the potential role of CLN3. Here, the anterograde transport of GM1 to the plasma membrane presented a positive correlation with the amount of full-length CLN3. In case of the truncated protein this correlation was missing, resulting in reduced PM staining with CTxB-FITC. However, transfection of full-length CLN3 in these cells restored the CTxB-FITC intensity. Based on the neuroprotective role of GM1, the corresponding increase in GM1 levels may be the cause for the restoration effects observed in previous studies using full-length CLN3. Hence, administration of GM1 was expected to improve cell viability of homozygous CbCln3Δex7/8 cells and beyond that to rescue potentially some disease phenotypes. However, no effect could be observed. The reason for this may be reduced caveolar uptake and the mislocalization of ganglioside GM1 to the trans-Golgi network (TGN) and redirection towards degradative compartments.
Both are in line with the idea of an impaired endocytic flux in CLN3 deficiency. The observed localization of CLN3 in the TGN suggests a potential role for CLN3 in the lipid sorting machinery, subsequently altering membrane composition and its regulatory functions. The resulting imbalance may affect many of the cellular processes impaired in JNCL.
Primäre Tumore werden nach ihrem Entstehungsort benannt. Selbst Metastasen zeigen eine gewisse Ähnlichkeit mit ihrem ursprünglichen Gewebe. Somit gehören alle Geschwülste, die ursprünglich der Harnblase entstammen, zu den Harnblasenkarzinomen.
Das Harnblasenkarzinom geht meist (90-95%) von der Schleimhaut der ableitenden Harnwege aus und wird als Urothel bezeichnet. Dementsprechend haben die meisten Patienten mit der Diagnose Blasenkarzinom ein Urothel-Blasenkarzinom. Die restlichen Blasenkarzinome entfallen auf Adenokarzinome, Plattenepithelkarzinome, kleinzellige Karzinome, Sarkome, Paragangliome, Melanome oder Lymphome (Humphrey A. et al. 2016, Moch H. et al 2016).
Die Urothel-Blasenkarzinome können sowohl flach, als auch warzenförmig wachsen. Je nach Diagnostik „oberflächlich“ oder „muskelinvasiv“ lassen sich die Urothel-Blasenkarzinome in zwei Hauptgruppen unterteilen;
Etwa 70% der Erkrankten haben dabei ein oberflächliches Urothel-Blasenkarzinom, das auf die Blasenschleimhaut begrenzt ist und durch eine Basistherapie, sog. Transurethrale Resektion (TUR-B) behandelt wird. Dabei werden die in der Schleimhaut gewachsenen Tumore getrennt reseziert. Therapieergänzend und/oder prophylaktisch wird die Blase danach mit einem Chemotherapeutikum gespült (intravesikale Instillation). Diese Zytostatika-Behandlung soll das Wiederauftreten eines Rezidivs verhindern bzw. eventuell verlangsamen (Iida K. et al. 2016, Celik O. et al. 2016).
Mitochondrial membrane dynamics is increasingly implicated in various human diseases. Numerous studies show that the protein OPA1 plays a central role in determining mitochondrial ultrastructure and apoptotic remodeling of the inner mitochondrial membrane during Cytochrome c release and apoptosis. Crista junctions are crucial for the regulation of apoptotic Cytochrome c release. Previous publications suggest that OPA1 is required to maintain a normal structure of the inner mitochondrial membrane. The protein MIC60 (Mitofilin) appears to be an essential physical constituent of crista junctions and is also crucial for the general determination of mitochondrial ultrastructure. Furthermore, recent studies suggest that MIC60 is also implicated in Cytochrome c release during apoptosis.
In this regard, the question whether OPA1 is essential for crista junction formation was investigated. In addition to that, the interplay between OPA1 and MIC60 and its physiological role were analyzed. Electron microscopy of OPA1+/- and OPA1+/+ mice, as well as of OPA1-/- and OPA1+/+ MEFs clearly showed that OPA1 plays a role but is not essential for crista junction formation. In contrast to that, the results indicate that OPA1 is crucial to maintain a normal structure of the inner mitochondrial membrane. Immunogold experiments fit well to these observations as OPA1 was found equally distributed throughout the cristae membrane with only a minor part located at crista junctions. MIC60 localization studies showed a clear enrichment at crista junctions. Interaction studies revealed that endogenous OPA1 and MIC60 physically interact with each other. Analysis of protein levels upon OPA1 or MIC60 depletion indicate that both proteins play a dual role in cristae- and crista junction formation in which MIC60 is a physical constituent of crista junctions essential for their formation while OPA1 primarily has a regulatory impact on MIC60 function. Finally, apoptosis assays and cell viability measurements showed that knockout of OPA1 in MEFs leads to increased cellular resistance suggesting that the interplay of these proteins is important for the regulation of crista junction remodeling during apoptosis.
Besides its role in determining mitochondrial ultrastructure, OPA1 mediates inner membrane fusion of mitochondria thereby contributing to mitochondrial quality control. Additionally, proteolytic processing is crucial for the ability of OPA1 to distinguish between functional and dysfunctional mitochondria. Functional mitochondria are fused while dysfunctional mitochondria are not, a process termed selective mitochondrial fusion. Dysfunctional mitochondria were shown to be degraded by mitophagy in a fission-dependent manner. Numerous studies suggest that OPA1 and mitophagy are directly linked. However, this idea is still under debate. Mitophagy is also crucial for mitochondrial quality control, which directly impacts mitochondrial integrity. Furthermore, mitochondrial quality control has been linked to neurodegeneration as demonstrated by the observation that mutations in OPA1 cause the disorder ADOA-1.
In order to analyze a potential link between OPA1 and mitophagy, mitochondrial colocalization with LC3 was analyzed microscopically in primary adult skin fibroblasts isolated from OPA1+/- and OPA1+/+ mice in an age-dependent manner. Fibroblasts from young OPA1+/- mice showed increased colocalization of mitochondria with autophagosomes compared to fibroblasts from young wild type mice suggesting that OPA1 exerts an inhibitory role in mitophagy. This effect was even more pronounced in old mice, which also displayed higher mitophagy levels in general than young mice, consistent with the finding that old mice had higher Parkin levels than young mice. Mitochondrial fragmentation was elevated in fibroblasts from young and old OPA1+/- mice compared to control fibroblasts. However, extensive mitochondrial fusion, which occurred in fibroblasts from old wild type mice, was prevented in old OPA1+/- mice. Furthermore, old wild type mice had decreased numbers of crista junctions compared to young wild type mice, an effect that was not observed in OPA1+/- mice. Despite the observed age-dependent phenotypes in mitochondrial quality control and mitochondrial integrity, deletion of one allele of OPA1 had no influence on the life span in vivo. Analysis of the OPA1-dependent proteome of aging mice, which was performed in collaboration with Ansgar Poetsch and Carina Ramallo-Guevara from Bochum, showed that OPA1-dependent aging is accompanied by a reduction of proteins involved in autophagy. In contrast to that, a switch from glucose to fatty acid metabolism and alterations in apoptotic proteins were observed in both OPA1+/- and OPA1+/+ mice in an age-dependent manner indicating that the changes in proteins implicated in autophagy could be a compensatory response to the diminished inhibitory effect of OPA1 on mitophagy. On the other hand, increased mitochondrial degradation by mitophagy could be a cellular response to itself compensating for the loss of OPA1 mediated fusion thereby contributing to the observation that OPA1+/- and OPA1+/+ mice had no differences in life span. Furthermore, analysis of the OPA1-dependent proteome of aging mice revealed that OPA1, besides its role in mitochondrial fusion, could interact with the fission machinery: MFF and Neuronal pentraxin 1, two proteins involved in mitochondrial fission, were up-regulated in 12-month-old OPA1+/- mice suggesting that a reduced fission activity could contribute to mitochondrial hyperfusion in aged wild- type mice. Nonetheless, the exact nature of the possible interplays between OPA1 and these candidates remains to be investigated.